AtriCure, Inc. (ATRC) is in Healthcare, Medical Instruments & Supplies, based in United States, listed on NasdaqGM. Market cap 2.69B USD. 52-week range 25.36 to 61.70 USD. Trailing P/E 251.6. Data as of 2026-10-09.
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the ...